A Crowded Pipeline Means Strategic Differentiation Is Critical With over 100 assets in clinical development, ranging from multi-agonists like retatrutide (with potential for ~25% weight loss) to oral small molecules like orforglipron , the battle for clinical and commercial leadership will be intense [3]
Elmonem MA, Veys KRP, Prencipe G (2022) Nephropathic cystinosis: pathogenic roles of inflammation and potential for new therapies
Store at a temperature not exceeding 25 C in a cool, dry place, away from sunlight
Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
Additionally, the cyclic trisulfide structure of LASSS, as opposed to the linear trisulfides such as GSSSG and cysteine trisulfide (Cys-SSS-Cys), could guarantee the unique reactivity of LASSS (see again Figure 1a for chemical structures)
NCT02207374